Heather
Brandling-Bennett
MD
Appointments
Seattle Children's
206.987.2158
Schedule Online
4800 Sand Point Way NE
Seattle, WA 98105
Biography
Dr. Heather Brandling-Bennett is an Associate Professor in the Department of Pediatrics with an adjunct appointment in the Department of Medicine at the University of Washington School of Medicine. She graduated from Dartmouth College with a B.A. in Psychology and Biology, and then earned her M.D. from Harvard Medical School. She completed her internship in Pediatrics at Massachusetts General Hospital and residency in Dermatology at the Harvard Combined Dermatology Residency Training Program, followed by a fellowship in Pediatric Dermatology at Columbia University.
She is a member of the Society for Pediatric Dermatology (SPD), Pediatric Dermatology Research Alliance (PeDRA), Childhood Arthritis and Rheumatology Research Alliance (CARRA), Foundation for Ichthyosis & Related Skin Types (FIRST) Medical & Scientific Advisory Board, American Academy of Dermatology (AAD), and Washington State Dermatology Association (WSDA). She currently serves as the SPD Vice President of Workforce & Specialty Advocacy, co-chair of the PeDRA Best Practices in Pediatric Dermatology Task Force, and President of the WSDA.
Education & Training
MD, Harvard Medical School, Boston MA, 2004
Internship in Pediatrics, Massachusetts General Hospital, Boston, MA, 2004-2005
Residency in Dermatology, Harvard Medical School, Boston MA, 2005-2008
Fellowship in Pediatric Dermatology, Columbia University Medical Center, New York NY 2008-2009
BA, Dartmouth College, Hanover NH 1999
Honors
Seattle Top Docs (Seattle Met Magazine) (2016)
Seattle Top Docs (Seattle Magazine) (2018)
Seattle Top Docs (Seattle Magazine) (2019)
Seattle Top Docs (Seattle Met Magazine) (2020)
Research Interests
- Dermatologic manifestations of autoimmune connective tissue disorders
- Psoriasis
- Complications from oncologic treatment
- Pediatric Dermatology workforce
Clinical Interests
- Dermatologic manifestations of autoimmune connective tissue disorders
- Psoriasis
- Disorders of keratinization
- Vascular anomalies
- Complications from oncologic treatment
Publications
Selected Publications
Do N, Ringold S, Sullivan E, Brandling-Bennett H. A retrospective study: Impact of consensus treatment plans on systemic therapy of pediatric morphea. Pediatr Dermatol 2020;37(2):278-283. PMID: 31967352
Do N, Ringold S, Brandling-Bennett H. Cutaneous polyarteritis nodosa in pediatric patients successfully treated with TNF-α inhibitor and methotrexate: Case series and literature review. Pediatr Dermatol 2019;36(6):932-935. PMID: 31576593
Arkin L, Buhr K, Brandling-Bennett HA, et al. Practice-based differences in pediatric discoid lupus erythematosus. Br J Dermatol 2019;181(4):805-10. PMID: 30768778
Kushner CJ, Tarazi M, Gaffney RG, Feng R, Ardalan K, Brandling-Bennett HA, et al. Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in pediatric cutaneous lupus among pediatric dermatologists and rheumatologists. Br J Dermatol 2019;180(1):165-71. PMID: 30033560
Prindaville B, Horii KA, Siegfried EC, Brandling-Bennett H. Pediatric dermatology workforce in the United States. Pediatr Dermatol 2019;36(1):166-8. PMID: 30318628